Loading...

Yvonne Ou, MD

TitleAssociate Professor
SchoolUCSF School of Medicine
DepartmentOphthalmology
Address10 Koret Way
San Francisco CA 94117
Phone415-476-0779
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Harvard CollegeB.A.Biochemical Sciences
    Harvard Medical SchoolM.D.
    Brigham & Women's HospitalInternshipInternal Medicine
    Jules Stein Eye Institute/UCLAResidencyOphthalmology
    Duke UniversityClinical and Research FellowshipGlaucoma

    Collapse Overview 
    Collapse Overview
    Our laboratory studies the cellular and synaptic mechanisms of glaucomatous neurodegeneration. We are particularly interested in understanding the earliest steps of inner retina circuit disassembly in response to injury. Our research program combines imaging and analysis of specific cell and synaptic labels in the retina, rodent models of experimental glaucoma, novel genetic tools in which specific cell types are labeled, and the tools of molecular/cell biology and physiology to address a series of questions that, unanswered, have prevented progress in the field: 1) What are the early steps of compartmentalized neurodegeneration of the ganglion cell in glaucoma? 2) Are there specific ganglion cell types that are more susceptible to intraocular pressure (IOP) elevation? 3) Are there specific inner retinal circuits that are more susceptible to IOP elevation? As a clinician-scientist, I am motivated to advance our field not only by answering these fundamental questions, but also by translating the knowledge gained into improvements in diagnostic and treatment modalities in glaucoma. For example, a detailed understanding of the earliest structural and functional changes that occur in glaucoma will allow us to design treatments that can rescue RGCs, perhaps the most susceptible RGCs, before irreversible cell death occurs. Our long-term goal is to understand the mechanisms underlying ganglion cell degeneration and circuit remodeling in glaucoma in order to improve diagnosis and treatment.


    Collapse Research 
    Collapse Research Activities and Funding
    Compartmentalized neurodegeneration of retinal ganglion cells in glaucoma
    NIH K08EY022676Sep 15, 2012 - Aug 31, 2017
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse Global Health
    Collapse Student Projects

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Zhang L, Li G, Shi M, Liu HH, Ge S, Ou Y, Flanagan JG, Chen L. Establishment and Characterization of an Acute Model of Ocular Hypertension by Laser-Induced Occlusion of Episcleral Veins. Invest Ophthalmol Vis Sci. 2017 Aug 01; 58(10):3879-3886. PMID: 28763561.
      View in: PubMed
    2. Chang I, Caprioli J, Ou Y. Surgical Management of Pediatric Glaucoma. Dev Ophthalmol. 2017; 59:165-178. PMID: 28442696.
      View in: PubMed
    3. Mao M, Kiss M, Ou Y, Gould DB. Genetic dissection of anterior segment dysgenesis caused by a Col4a1 mutation in mouse. Dis Model Mech. 2017 Apr 01; 10(4):475-485. PMID: 28237965.
      View in: PubMed
    4. Ou Y, Jo RE, Ullian EM, Wong RO, Della Santina L. Selective Vulnerability of Specific Retinal Ganglion Cell Types and Synapses after Transient Ocular Hypertension. J Neurosci. 2016 Aug 31; 36(35):9240-52. PMID: 27581463; PMCID: PMC5005727 [Available on 03/03/17].
    5. Della Santina L, Ou Y, et al. Who's lost first? Susceptibility of retinal ganglion cell types in experimental glaucoma. Exp Eye Res. 2017 May; 158:43-50. PMID: 27319294.
      View in: PubMed
    6. Kuo DS, Ou Y, Jeng BH, Bhisitkul R, Stewart JM, Duncan JL, Han Y. Correlation of Serial Scleral and Corneal Pneumatonometry. Ophthalmology. 2015 Sep; 122(9):1771-6. PMID: 26165473; PMCID: PMC4549181.
    7. Schallhorn JM, Schallhorn SC, Ou Y. Factors that influence intraocular pressure changes after myopic and hyperopic LASIK and photorefractive keratectomy: a large population study. Ophthalmology. 2015 Mar; 122(3):471-9. PMID: 25444636.
      View in: PubMed
    8. Lin CC, Chen A, Jeng BH, Porco TC, Ou Y, Han Y. Scleral intraocular pressure measurement in cadaver eyes pre- and postkeratoprosthesis implantation. Invest Ophthalmol Vis Sci. 2014 Apr 09; 55(4):2244-50. PMID: 24557348.
      View in: PubMed
    9. Law SK, Tamboli DA, Ou Y, Giaconi JA, Caprioli J. Development of a resident training module for systematic optic disc evaluation in glaucoma. J Glaucoma. 2012 Dec; 21(9):601-7. PMID: 21602706.
      View in: PubMed
    10. Ou Y, Grossman DS, Lee PP, Sloan FA. Glaucoma, Alzheimer disease and other dementia: a longitudinal analysis. Ophthalmic Epidemiol. 2012 Oct; 19(5):285-92. PMID: 22978529; PMCID: PMC3523354.
    11. Ou Y, Caprioli J. Surgical management of pediatric glaucoma. Dev Ophthalmol. 2012; 50:157-72. PMID: 22517182.
      View in: PubMed
    12. Ou Y, Goldberg I, Migdal C, Lee PP. A critical appraisal and comparison of the quality and recommendations of glaucoma clinical practice guidelines. Ophthalmology. 2011 Jun; 118(6):1017-23. PMID: 21507487.
      View in: PubMed
    13. Ou Y, Yu F, Law SK, Coleman AL, Caprioli J. Outcomes of Ahmed glaucoma valve implantation in children with primary congenital glaucoma. Arch Ophthalmol. 2009 Nov; 127(11):1436-41. PMID: 19901208.
      View in: PubMed
    14. Nelson T, To KF, Wong YY, Dickinson J, Choi KC, Yu LM, Ou Y, Chow CB, Wong E, Tang N, Hjelm M, Chen L. Hong Kong case-control study of sudden unexpected infant death. N Z Med J. 2005 Dec 16; 118(1227):U1788. PMID: 16372037.
      View in: PubMed
    15. Wang GS, Hong CJ, Yen TY, Huang HY, Ou Y, Huang TN, Jung WG, Kuo TY, Sheng M, Wang TF, Hsueh YP. Transcriptional modification by a CASK-interacting nucleosome assembly protein. Neuron. 2004 Apr 08; 42(1):113-28. PMID: 15066269.
      View in: PubMed
    16. Wang TF, Ou Y, Guidotti G. The transmembrane domains of ectoapyrase (CD39) affect its enzymatic activity and quaternary structure. J Biol Chem. 1998 Sep 18; 273(38):24814-21. PMID: 9733785.
      View in: PubMed
    Yvonne's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP